Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Costi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
JMIR Medical Education|November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey StudyJacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
Brain, Behavior, and Immunity|May 31, 2022
Exaggerated amygdala response to threat and association with immune hyperactivity in depressionSarah Boukezzi, Sara Costi, Lisa M Shin, et al.
Neurobiology of Stress|January 9, 2023
A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adultsSara Costi, Audrey Evers, Manish K Jha, et al.
Biological Psychiatry|March 6, 2025
Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled TrialAvijit Chowdhury, Sarah Boukezzi, Sara Costi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Social stress induces autoimmune responses against the brainYusuke Shimo, Flurin Cathomas, Hsiao-Yun Lin, et al.
Molecular Psychiatry|March 26, 2025
Effects of KCNQ potassium channel modulation on ventral tegmental area activity and connectivity in individuals with depression and anhedoniaLaurel S Morris, Sara Costi, Sara Hameed, et al.
Translational Psychiatry|January 11, 2022
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depressionFlurin Cathomas, Laura Bevilacqua, Aarthi Ramakrishnan, et al.
The International Journal of Neuropsychopharmacology|November 30, 2017
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress DisorderSehrish Sayed, Nicholas T Van Dam, Sarah R Horn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 13, 2019
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trialSara Costi, Laili Soleimani, Andrew Glasgow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 2021
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidenceAgnes Norbury, Sarah B Rutter, Abigail B Collins, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
JMIR Medical Education|November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey StudyJacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
Brain, Behavior, and Immunity|May 31, 2022
Exaggerated amygdala response to threat and association with immune hyperactivity in depressionSarah Boukezzi, Sara Costi, Lisa M Shin, et al.
Neurobiology of Stress|January 9, 2023
A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adultsSara Costi, Audrey Evers, Manish K Jha, et al.
Biological Psychiatry|March 6, 2025
Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled TrialAvijit Chowdhury, Sarah Boukezzi, Sara Costi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Social stress induces autoimmune responses against the brainYusuke Shimo, Flurin Cathomas, Hsiao-Yun Lin, et al.
Molecular Psychiatry|March 26, 2025
Effects of KCNQ potassium channel modulation on ventral tegmental area activity and connectivity in individuals with depression and anhedoniaLaurel S Morris, Sara Costi, Sara Hameed, et al.
Translational Psychiatry|January 11, 2022
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depressionFlurin Cathomas, Laura Bevilacqua, Aarthi Ramakrishnan, et al.
The International Journal of Neuropsychopharmacology|November 30, 2017
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress DisorderSehrish Sayed, Nicholas T Van Dam, Sarah R Horn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 13, 2019
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trialSara Costi, Laili Soleimani, Andrew Glasgow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 2021
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidenceAgnes Norbury, Sarah B Rutter, Abigail B Collins, et al.
Pageof 3